Source: http://news.yahoo.com/germany-39-stance-pricing-threatens-drug-firm-profits-070456703--sector.html
Friday, February 21, 2014
Germany's stance on pricing threatens drug firm profits
By Ludwig Burger and Thorsten Severin FRANKFURT/BERLIN (Reuters) - Germany's plan to publish price discounts agreed with drugmakers poses a risk to profits in the industry, which fears the information could be used to drive down prices elsewhere. Germany, Europe's biggest market for medicines, is already one of the toughest for pharmaceutical companies, in part because statutory health insurers ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment